Component Type: Session
Traditional study planning, driven by the number of sites estimated to achieve enrollment, is filled with inefficiencies and significant delays. Together with a key client, PPD’s Accelerated Enrollment Solutions business unit pioneered a new way to integrate the site network into study design to drastically reduces startup times and increases consistency/quality of data and study conduct. This new model is helping bring a lipid-lowering therapy with potential to change millions of lives to market in unprecedented timelines. This case study presentation highlights:
- Shared sense of purpose and accountability across this program to deliver for the greater good and impact to global healthcare system
- Change management on a global- and industry- scale to change the longstanding approach to study startup
- Collaboration to generate evidence: unified to overcome obstacles and nimble to develop new approaches
- The combination of patient data, modeling, direct marketing, predictive analytics to identify qualified patients and deliver enrollment volume and certainty
This unique approach illustrates how a sponsor and CRO can come together to change the face of drug development.
Chair PPD, Inc.
